DOCSLIB.ORG

Reference Standards Tables

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Reference Standards Tables Reference Standards Tables Below are several tables with the latest Reference Standard information including out-of-stock items now available; new Reference Standards released in the last month; backordered items with estimated availability dates; items with lots that are no longer valid (or soon will be invalid); and items with new lots since the last newsletter. USP strongly suggest downloading the FREE Reference Standards and Resources APP to easily track and receive notifications and alerts for the Reference Standards of interest to you. Please contact your USP Customer Service Representative to place an order at +1-301-881-0666 or 1-800-227-8772. European customers can call 00-800-4875-5555. You can also order online at http://www.usp.org/products New Reference Standards Now Available Items With Replacement Lots Backorder Availability Report As of August 29, 2018 Previously Out-of-Stock Items Now Available No Longer Valid as of September 2018 New Reference Standards Now Available Catalog # Description Current Lot Start Date# Price 1606079 Rotigotine Hydrochloride (300 mg) ((6S )-6- F086D0 28-Aug-18 $930.00 [Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8- tetrahydronaphthalen-1-ol hydrochloride) Return To The Top Items with Replacement Lots Catalog# Description Current Previous Lot (Valid Price Lot Use Date) 1021000 Aminocaproic Acid (200 mg) R09420 I0M248 (31-Jul-19) $230.00 1031558 Amoxicillin Related Compounds D R08840 F0J382 (31-Jul-19) $805.00 and E Mixture (15 mg) 1032007 Amphotericin B (125 mg) (COLD R087G0 K1M387 (31-Mar-19) $185.00 SHIPMENT REQUIRED) 1042780 Artemether (100 mg) R098G0 H0M313 (31-Jul-19) $230.00 1048620 Benazepril Related Compound A (25 R088H0 H1M034 (31-Aug-19) $730.00 mg) ((3R)-3-[[(1R)-1- (ethoxycarbonyl)-3- phenylpropyl]amino]-2,3,4,5- tetrahydro-2-oxo-1H-1-benzazepine- 1-acetic acid, monohydrochloride) 1050905 Benzaldehyde (3 X 1 mL) (List R079U0 I0M304 (31-Aug-19) $230.00 Chemical) 1071381 Biochanin A (20 mg) R105N0 F0L141 (31-May-19) $200.00 1086866 Calcium (-)-Hydroxycitrate (150 mg) R073A0 F0K014 (28-Feb-19) $255.00 1157002 Cyclophosphamide (500 mg) R095Y0 R075X0 (31-Mar-19) $185.00 1180503 Dextromethorphan (500 mg) R082F0 I3F274 (31-Aug-19) $245.00 1185008 Diazepam CIV (100 mg) R079N0 R005P0 (30-Jun-19) $305.00 1200804 Dihydrocodeine Bitartrate CII (200 J1K044 J0K044 (31-Aug-19) $305.00 mg) 1225281 Dorzolamide Hydrochloride (200 mg) R095U0 R036L0 (30-Jun-19) $230.00 1228009 Drometrizole (25 mg) (2-(2H- R100T0 F0J261 (31-May-19) $230.00 Benzotriazol-2-yl)-p-cresol) 1237509 Epitetracycline Hydrochloride (250 R095C0 R064D0 (31-Dec-18) $805.00 mg) 1279826 Fluoxetine Related Compound B (5 R092W0 R04500 (31-Dec-18) $805.00 mL of a 0.01N HCl Solution, approx. 2 mg/mL) (N-Methyl-3-phenylpropan- 1-amine) 1291559 Ginkgo Terpene Lactones (50 mg) R088U0 I0K042 (31-May-19) $415.00 1330005 Hypromellose (250 mg) R08850 H1H066 (30-Jun-19) $265.00 (Hydroxypropyl Methylcellulose) 1358503 Leuprolide Acetate (1.97 mg) R060Y0 I0M442 (31-Mar-19) $2,580.00 (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) 1375502 Mebendazole (200 mg) R096E0 R042U0 (30-Jun-19) $230.00 1424051 Methyl Acetate (1.2 mL/ampule; 3 R06450 G0L454 (30-Jun-19) $225.00 ampules) 1430327 Methyl Linoleate (5 x 50 mg) R094E0 R055J0 (30-Jun-19) $200.00 1457469 Naratriptan Hydrochloride (125 mg) R08470 G0I229 (31-Jul-19) $305.00 1457630 Nateglinide Related Compound C (20 R09720 F0I014 (30-Jun-19) $730.00 mg) (N-(cis-4- isopropylcyclohexanecarbonyl)-D- phenylalanine) 1463371 Nicotine Related Compound F (20 F001L1 F001L0 (30-Nov-18) $730.00 mg) (3-(pyrrolidin-2-yl)pyridine) 1500400 Parthenolide (25 mg) R10040 G0F255 (31-May-19) $200.00 1533024 Phenylephrine Related Compound C R078B0 F00210 (31-Aug-19) $805.00 (30 mg) (1-(3-Hydroxyphenyl)-2- (methylamino)ethan-1-one hydrochloride) 1539009 Pilocarpine Nitrate (200 mg) R098S0 R06410 (31-Jul-19) $230.00 1565009 Procarbazine Hydrochloride (200 mg) F2K338 F1K338 (31-Jul-19) $230.00 1578554 Prostaglandin B1 (25 mg) ((13E,15S)- R080M0 G0M011 (30-Jun-19) $2,060.00 15-Hydroxy-9-oxoprosta-8(12),13- dien-1-oic Acid) 1604870 Rivastigmine Related Compound B R096D0 R028R0 (31-Aug-19) $730.00 (15 mg) ((R,S)-3-[1- (Dimethylamino)ethyl]phenyl dimethylcarbamate) 1617420 Sotalol Related Compound B (50 mg) R094F0 G0L564 (31-May-19) $730.00 (N-(4- Formylphenyl)methanesulfonamide) 1711100 Vasopressin (1.68 mg) (8-L-arginine R09120 H0L444 (31-Mar-19) $280.00 vasopressin) (COLD SHIPMENT REQUIRED) Return To The Top Backorder Availability As of August 29th Catalog # Description Estimated Availability 1011878 Adrenalone Hydrochloride (25 mg) (3',4'-Dihydroxy-2- Q3 (methylamino)acetophenone hydrochloride) 1012780 Alendronate Sodium (200 mg) Q3 1044516 Atorvastatin Calcium (100 mg) Q4 1045009 Atropine Sulfate (500 mg) Q3 1051001 Benzalkonium Chloride (5 mL of approx. 10% aqueous solution) Q3 1086006 Caffeine Melting Point Standard (1 g) (Approximately 236 degrees) Q3 1087009 Calcium Pantothenate (200 mg) (Vitamin B5) Q4 1098130 Ceftazidime Pentahydrate (300 mg) Q3 1134379 Clarithromycin (100 mg) Q3 1142005 Cloxacillin Sodium (200 mg) Q3 1151866 Curcuminoids (300 mg) Q4 1158650 Cyclosporine Resolution Mixture (25 mg) (This material is an Q3 approximate 100:1 (w/w) mixture of cyclosporine and cyclosporine U) 1193505 Diethyl Phthalate (200 mg) Q4 1237600 Epoprostenol Sodium (100 mg) (COLD SHIPMENT REQUIRED) Q4 1241550 Ergotaminine (100 mg) Q4 1257018 Ethambutol Related Compound A (15 mg) ((2R,2'S)-2,2'-[ethane-1,2- Q3 diylbis(azanediyl)]dibutan-1-ol) 1274607 Flunixin Meglumine (300 mg) Q4 1280009 Fluoxymesterone CIII (200 mg) Q4 1282004 Fluphenazine Hydrochloride (125 mg) Q4 1291446 Ginger Constituent Mixture (0.2 mg) (6-gingerol and 6-shogaol) Q3 1325005 Hydroxyamphetamine Hydrobromide (200 mg) TBD 1342208 Insulin (Beef) (50 mg) (COLD SHIPMENT REQUIRED) Q4 1355006 Kanamycin Sulfate (200 mg) Q4 1361010 Levodopa Related Compound A (50 mg) ((3-(2,4,5-Trihydroxyphenyl)-L- Q4 alanine) or (3-(3,4,6-Trihydroxyphenyl)alanine)) 1365021 Levothyroxine for Peak Identification (15 mg) (levothyroxine sodium Q4 spiked with liothyronine, triiodothyroacetic acid, tetraiodothyroacetic acid) 1377803 Meclofenamate Sodium (500 mg) Q4 1381119 Menaquinone-7 (3 x 50 mg) (Vitamin K2) Q4 1395204 Metacresol (1 mL) Q3 1422001 Methsuximide (500 mg) Q3 1444235 Mirtazapine Related Compound B (25 mg) (1,2,3,4,10,14b-Hexahydro- Q3 2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate) 1478200 Oleyl Oleate (0.5 mL) Q4 1481226 Oxaliplatin Related Compound B (15 mg) ([SP-4-2-(1R-trans)]-(1,2- Q3 cyclohexanediamine-N,N') dinitratoplatinum(II)) 1500003 Paromomycin Sulfate (125 mg) Q3 1504503 Penicillin V Potassium (200 mg) Q4 1530004 Phentolamine Mesylate (200 mg) Q3 1543200 Piperine (20 mg) Q3 1561507 Primaquine Phosphate (200 mg) Q4 1578000 Propylthiouracil (200 mg) Q4 1600121 Rebaudioside A (500 mg) Q4 1601703 Residual Solvent Class 2 - N-Methylpyrrolidone (1.2 mL/ampule; 3 Q4 ampules) 1605512 Ropivacaine Related Compound A (25 mg) (2,6-dimethylaniline Q4 hydrochloride) 1607040 Saccharin Sodium (100 mg) Q3 1612007 Sennosides (500 mg) Q4 1612630 Silybin (50 mg) Q4 1642100 Sulisobenzone (500 mg) Q3 1667643 Tigecycline (300 mg) (INTERNATIONAL COLD CHAIN SHIPMENT Q4 REQUIRED) 1675007 Triacetin (1 g) Q3 1711009 Vanillin Melting Point Standard (1 g) (Approximately 82 degrees) Q4 1712023 Vigabatrin Related Compound B (30 mg) ((E)-2-(2-aminoethyl)but-2- TBD enoic acid hydrochloride) 1713004 Vinblastine Sulfate (50 mg) Q4 1724441 Ziprasidone Related Compound C (10 mg) (5,5'-Bis(2-(4- Q4 (benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6'-dichloro-3-hydroxy- 3,3'-biindoline-2,2'-dione) *Dates are targets and may change at any time. Q1January—March, Q2 April –June, Q3- July – September, Q4- October –December Return To The Top Previously Out of Stock Items Now Available Catalog # Description and Package Size Lot Price 1370291 Loratadine Related Compound B (15 mg) (8-Chloro-11- R049Q0 $805.00 (1-methylpiperidin-4-ylidene)-6,11-dihydro-5H- benzo[5,6]cyclohepta[1,2-b]pyridine) 1005004 Acetazolamide (2 g) R089P0 $230.00 1667600 Alpha Tocopherol (250 mg) (PART-2) R094X0 $230.00 1021000 Aminocaproic Acid (200 mg) R09420 $230.00 1032007 Amphotericin B (125 mg) (COLD SHIPMENT REQUIRED) R087G0 $185.00 1042780 Artemether (100 mg) R098G0 $230.00 1048620 Benazepril Related Compound A (25 mg) ((3R)-3-[[(1R)-1- R088H0 $730.00 (ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5- tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) 1050905 Benzaldehyde (3 X 1 mL) (List Chemical) I0M304 $230.00 1071381 Biochanin A (20 mg) R105N0 $200.00 1086866 Calcium (-)-Hydroxycitrate (150 mg) R073A0 $255.00 1087009 Calcium Pantothenate (200 mg) (Vitamin B5) R029P0 $230.00 1096860 Carnauba Wax (200 mg) R092Y0 $255.00 1098027 Cefpodoxime Proxetil (350 mg) R044K0 $230.00 1157002 Cyclophosphamide (500 mg) R095Y0 $185.00 1180503 Dextromethorphan (2 g) I3F274 $245.00 1294319 D-Glucuronic Acid (50 mg) R076L0 $280.00 1185008 Diazepam CIV (100 mg) R079N0 $305.00 1225281 Dorzolamide Hydrochloride (200 mg) R095U0 $230.00 1228009 Drometrizole (25 mg) (2-(2H-Benzotriazol-2-yl)-p-cresol) R100T0 $230.00 1234147 Efavirenz Related Compound B (10 mg) ((S,E)-6-Chloro-4- R090U0 $805.00 (2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1- benzoxazin-2-one 1237509 Epitetracycline Hydrochloride (250 mg) R095C0 $805.00 1279826 Fluoxetine Related Compound B (5 mL of a 0.01N HCl R092W0 $805.00 Solution, approx. 2 mg/mL) (N-Methyl-3-phenylpropan-1- amine) 1280009 Fluoxymesterone CIII (200 mg) G4F292 $305.00 1291559
Load more

Recommended publications
  • 6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger
    International Journal of Molecular Sciences Article 6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed Mice Chien-Kei Wei 1,†, Yi-Hong Tsai 1,†, Michal Korinek 1, Pei-Hsuan Hung 2, Mohamed El-Shazly 1,3, Yuan-Bin Cheng 1, Yang-Chang Wu 1,4,5,6, Tusty-Jiuan Hsieh 2,7,8,9,* and Fang-Rong Chang 1,7,9,* 1 Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807, Taiwan; [email protected] (C.-K.W.); [email protected] (Y.-H.T.); [email protected] (M.K.); [email protected] (M.E.-S.); [email protected] (Y.-B.C.); [email protected] (Y.-C.W.) 2 Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan; [email protected] 3 Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, Ain-Shams University, Cairo 11566, Egypt 4 School of Pharmacy, College of Pharmacy, China Medical University, Taichung 404, Taiwan 5 Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 404, Taiwan 6 Center for Molecular Medicine, China Medical University Hospital, Taichung 404, Taiwan 7 Department of Marine Biotechnology and Resources, College of Marine Sciences, National Sun Yat-sen University, Kaohsiung 804, Taiwan 8 Lipid Science and Aging Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan 9 Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan * Correspondence: [email protected] (T.-J.H.); [email protected] (F.-R.C.); Tel.: +886-7-312-1101 (ext.
    [Show full text]
  • In Vitro Immunopharmacological Profiling of Ginger (Zingiber Officinale Roscoe)
    Research Collection Doctoral Thesis In vitro immunopharmacological profiling of ginger (Zingiber officinale Roscoe) Author(s): Nievergelt, Andreas Publication Date: 2011 Permanent Link: https://doi.org/10.3929/ethz-a-006717482 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library DISS. ETH Nr. 19591 In Vitro Immunopharmacological Profiling of Ginger (Zingiber officinale Roscoe) ABHANDLUNG zur Erlangung des Titels DOKTOR DER WISSENSCHAFTEN der ETH ZÜRICH vorgelegt von Andreas Nievergelt Eidg. Dipl. Apotheker, ETH Zürich geboren am 18.12.1978 von Schleitheim, SH Angenommen auf Antrag von Prof. Dr. Karl-Heinz Altmann, Referent Prof. Dr. Jürg Gertsch, Korreferent Prof. Dr. Michael Detmar, Korreferent 2011 Table of Contents Summary 6 Zusammenfassung 7 Acknowledgements 8 List of Abbreviations 9 1. Introduction 13 1.1 Ginger (Zingiber officinale) 13 1.1.1 Origin 14 1.1.2 Description 14 1.1.3 Chemical Constituents 15 1.1.4 Traditional and Modern Pharmaceutical Use of Ginger 17 1.1.5 Reported In Vitro Effects 20 1.2 Immune System and Inflammation 23 1.2.1 Innate and Adaptive Immunity 24 1.2.2 Cytokines in Inflammation 25 1.2.3 Pattern Recognition Receptors 29 1.2.4 Toll-Like Receptors 30 1.2.5 Serotonin 1A and 3 Receptors 32 1.2.6 Phospholipases A2 33 1.2.7 MAP Kinases 36 1.2.8 Fighting Inflammation, An Ongoing Task 36 1.2.9 Inflammation Assays Using Whole Blood 38 1.3 Arabinogalactan-Proteins 39 1.3.1 Origin and Biological Function of AGPs 40 1.3.2 Effects on Animals 41 1.3.3 The ‘Immunostimulation’ Theory 42 1/188 2.
    [Show full text]
  • TRP Mediation
    molecules Review Remedia Sternutatoria over the Centuries: TRP Mediation Lujain Aloum 1 , Eman Alefishat 1,2,3 , Janah Shaya 4 and Georg A. Petroianu 1,* 1 Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] (L.A.); Eman.alefi[email protected] (E.A.) 2 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates 3 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman 11941, Jordan 4 Pre-Medicine Bridge Program, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] * Correspondence: [email protected]; Tel.: +971-50-413-4525 Abstract: Sneezing (sternutatio) is a poorly understood polysynaptic physiologic reflex phenomenon. Sneezing has exerted a strange fascination on humans throughout history, and induced sneezing was widely used by physicians for therapeutic purposes, on the assumption that sneezing eliminates noxious factors from the body, mainly from the head. The present contribution examines the various mixtures used for inducing sneezes (remedia sternutatoria) over the centuries. The majority of the constituents of the sneeze-inducing remedies are modulators of transient receptor potential (TRP) channels. The TRP channel superfamily consists of large heterogeneous groups of channels that play numerous physiological roles such as thermosensation, chemosensation, osmosensation and mechanosensation. Sneezing is associated with the activation of the wasabi receptor, (TRPA1), typical ligand is allyl isothiocyanate and the hot chili pepper receptor, (TRPV1), typical agonist is capsaicin, in the vagal sensory nerve terminals, activated by noxious stimulants.
    [Show full text]
  • Daikenchuto (Da-Jian-Zhong-Tang) Ameliorates Intestinal Fibrosis by Activating Myofibroblast Transient Receptor Potential Ankyrin 1 Channel
    Submit a Manuscript: http://www.f6publishing.com World J Gastroenterol 2018 September 21; 24(35): 4036-4053 DOI: 10.3748/wjg.v24.i35.4036 ISSN 1007-9327 (print) ISSN 2219-2840 (online) ORIGINAL ARTICLE Basic Study Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel Keizo Hiraishi, Lin-Hai Kurahara, Miho Sumiyoshi, Yao-Peng Hu, Kaori Koga, Miki Onitsuka, Daibo Kojima, Lixia Yue, Hidetoshi Takedatsu, Yu-Wen Jian, Ryuji Inoue Keizo Hiraishi, Lin-Hai Kurahara, Miho Sumiyoshi, Yao-Peng and No. 25860571; a MEXT-Supported Program supporting research Hu, Ryuji Inoue, Department of Physiology, Graduate School of activities of female researchers; the Clinical Research Foundation; Medical Sciences, Fukuoka University, Fukuoka 8140180, Japan and the Central Research Institute of Fukuoka University, No. 151045 and No. 147104. Kaori Koga, Miki Onitsuka, Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka 8140180, Japan Institutional review board statement: The study was reviewed and approved by the Clinical Research Ethics Committee of Daibo Kojima, Department of Gastroenterological Surgery, Faculty Fukuoka University, No. 15-10-04. of Medicine, Fukuoka University, Fukuoka 8140180, Japan Institutional animal care and use committee statement: All Lixia Yue, Department of Cell Biology, University of Connecticut procedures involving animals were reviewed and approved by Health Center, Farmington, CT 06030, United States the Animal experiment ethics committee of Fukuoka University, No. 1709099; and the Genetic Modification Experiment Safety Hidetoshi Takedatsu, Department of Gastroenterology and Commission of Fukuoka University approved experiments on Medicine, Faculty of Medicine, Fukuoka University, Fukuoka genetically modified animals, No. 167. 8140180, Japan Conflict-of-interest statement: The authors declare that they Yu-Wen Jian, College of Letters and Science, University of have no competing interests.
    [Show full text]
  • 6-Shogaol Induces Apoptosis in Human Leukemia Cells Through A
    Liu et al. Molecular Cancer 2013, 12:135 http://www.molecular-cancer.com/content/12/1/135 RESEARCH Open Access 6-Shogaol induces apoptosis in human leukemia cells through a process involving caspase-mediated cleavage of eIF2α Qun Liu1†, Yong-Bo Peng1†, Ping Zhou1, Lian-Wen Qi1, Mu Zhang1, Ning Gao2*, E-Hu Liu1* and Ping Li1* Abstract Background: 6-Shogaol is a promising antitumor agent isolated from dietary ginger (Zingiber officinale). However, little is known about the efficacy of 6-shogaol on leukemia cells. Here we investigated the underlying mechanism of 6-shogaol induced apoptosis in human leukemia cells in vitro and in vivo. Methods: Three leukemia cell lines and primary leukemia cells were used to investigate the apoptosis effect of 6-shogaol. A shotgun approach based on label-free proteome with LC-CHIP Q-TOF MS/MS was employed to identify the cellular targets of 6-shogaol and the differentially expressed proteins were analyzed by bioinformatics protocols. Results: The present study indicated that 6-shogaol selectively induced apoptosis in transformed and primary leukemia cells but not in normal cells. Eukaryotic translation initiation factor 2 alpha (eIF2α), a key regulator in apoptosis signaling pathway, was significantly affected in both Jurkat and U937 proteome profiles. The docking results suggested that 6-shogaol might bind well to eIF2α at Ser51 of the N-terminal domain. Immunoblotting data indicated that 6-shogaol induced apoptosis through a process involving dephosphorylation of eIF2α and caspase activation–dependent cleavage of eIF2α. Furthermore, 6-shogaol markedly inhibited tumor growth and induced apoptosis in U937 xenograft mouse model.
    [Show full text]
  • Optimization of Extraction Conditions for the 6-Shogaol-Rich Extract from Ginger (Zingiber Officinale Roscoe) Research Note Seon Ok1,2 and Woo-Sik Jeong1†
    Prev Nutr Food Sci Vol 17, p 166～171 (2012) http://dx.doi.org/10.3746/pnf.2012.17.2.166 Optimization of Extraction Conditions for the 6-Shogaol-rich Extract from Ginger (Zingiber officinale Roscoe) Research Note Seon Ok1,2 and Woo-Sik Jeong1† 1Department of Food and Life Sciences, College of Biomedical Science and Engineering, Inje University, Gyeongnam 621-749, Korea 2Department of Pharmacy, Kyungsung University, Busan 808-736, Korea Abstract 6-Shogaol, a dehydrated form of 6-gingerol, is a minor component in ginger (Zingiber officinale Roscoe) and has recently been reported to have more potent bioactivity than 6-gingerol. Based on the thermal instability of gingerols (their dehydration to corresponding shogaols at high temperature), we aimed to develop an optimal proc- ess to maximize the 6-shogaol content during ginger extraction by modulating temperature and pH. Fresh gingers were dried under various conditions: freeze-, room temperature (RT)- or convection oven-drying at 60 or 80oC, and extracted by 95% ethanol at RT, 60 or 80oC. The content of 6-shogaol was augmented by increasing both drying and extraction temperatures. The highest production of 6-shogaol was achieved at 80oC extraction after drying at the same temperature and the content of 6-shogaol was about 7-fold compared to the lowest producing process by freezing and extraction at RT. Adjustment of pH (pH 1, 4, 7 and 10) for the 6-shogaol-richest extract (dried and extracted both at 80oC) also affected the chemical composition of ginger and the yield of 6-shogaol was maximized at the most acidic condition of pH 1.
    [Show full text]
  • Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer
    Published OnlineFirst October 11, 2011; DOI: 10.1158/1940-6207.CAPR-11-0224 Cancer Prevention Research Article Research Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer Suzanna M. Zick1, D. Kim Turgeon3, Shaiju K. Vareed6, Mack T. Ruffin1, Amie J. Litzinger1, Benjamin D. Wright1, Sara Alrawi1, Daniel P. Normolle2, Zora Djuric1, and Dean E. Brenner3,4,5 Abstract Inhibitors of COX indicate that upregulation of inflammatory eicosanoids produced by COX, and in particular prostaglandin E2 (PGE2), are early events in the development of colorectal cancer (CRC). Ginger has shown downregulation of COX in vitro and decreased incidence/multiplicity of adenomas in rats. This study was conducted to determine if 2.0 g/d of ginger could decrease the levels of PGE2, 13-hydroxy- octadecadienoic acids, and 5-, 12-, and 15-hydroxyeicosatetraenoic acid (5-, 12-, and 15-HETE), in the colon mucosa of healthy volunteers. To investigate this aim, we randomized 30 subjects to 2.0 g/d ginger or placebo for 28 days. Flexible sigmoidoscopy at baseline and day 28 was used to obtain colon biopsies. A liquid chromatography mass spectrometry method was used to determine eicosanoid levels in the biopsies, and levels were expressed per protein or per free arachidonic acid. There were no significant differences in mean percent change between baseline and day 28 for any of the eicosanoids, when normalized to protein. There was a significant decrease in mean percent change in PGE2 (P ¼ 0.05) and 5-HETE (P ¼ 0.04), and a trend toward significant decreases in 12-HETE (P ¼ 0.09) and 15-HETE (P ¼ 0.06) normalized to free arachidonic acid.
    [Show full text]
  • New Natural Agonists of the Transient Receptor Potential Ankyrin 1 (TRPA1
    www.nature.com/scientificreports OPEN New natural agonists of the transient receptor potential Ankyrin 1 (TRPA1) channel Coline Legrand, Jenny Meylan Merlini, Carole de Senarclens‑Bezençon & Stéphanie Michlig* The transient receptor potential (TRP) channels family are cationic channels involved in various physiological processes as pain, infammation, metabolism, swallowing function, gut motility, thermoregulation or adipogenesis. In the oral cavity, TRP channels are involved in chemesthesis, the sensory chemical transduction of spicy ingredients. Among them, TRPA1 is activated by natural molecules producing pungent, tingling or irritating sensations during their consumption. TRPA1 can be activated by diferent chemicals found in plants or spices such as the electrophiles isothiocyanates, thiosulfnates or unsaturated aldehydes. TRPA1 has been as well associated to various physiological mechanisms like gut motility, infammation or pain. Cinnamaldehyde, its well known potent agonist from cinnamon, is reported to impact metabolism and exert anti-obesity and anti-hyperglycemic efects. Recently, a structurally similar molecule to cinnamaldehyde, cuminaldehyde was shown to possess anti-obesity and anti-hyperglycemic efect as well. We hypothesized that both cinnamaldehyde and cuminaldehyde might exert this metabolic efects through TRPA1 activation and evaluated the impact of cuminaldehyde on TRPA1. The results presented here show that cuminaldehyde activates TRPA1 as well. Additionally, a new natural agonist of TRPA1, tiglic aldehyde, was identifed
    [Show full text]
  • Antimicrobial Property and Phytochemical Study of Ginger Found in Local Area of Punjab, Pakistan
    Riaz et al., International Current Pharmaceutical Journal, June 2015, 4(7): 405-409 International Current http://www.icpjonline.com/documents/Vol4Issue7/03.pdf Pharmaceutical Journal ORIGINAL RESEARCH ARTICLE OPEN ACCESS Antimicrobial property and phytochemical study of ginger found in local area of Punjab, Pakistan Humayun Riaz1, Almas Begum2, Syed Atif Raza3, Zia Mohy-Ud-Din Khan1, *Hamad Yousaf1 and Ayesha Tariq4 1Rashid Latif College of Pharmacy Lahore, Pakistan 2Rashid Latif Medical College Lahore, Pakistan 3University College of Pharmacy, Punjab University, Lahore, Pakistan 4Faculity of Pharmacy, University of Central Punjab, Lahore Pakistan ABSTRACT The aim of study is to identify the antimicrobial property of ginger. Phytochemical screening of chloroform plant extract showed presence of different chemicals. In this study we used Cultures of E. Coli, Bacillus subtilis, Staphylococcus aureus and Streptococcus faecalis to identify the antimicrobial strength. Effectiveness of ginger against different conditions attributed to its different constitu- ents (volatile oils, shogaols, Gingerols and diarylheptanoids) that show their therapeutic efficacy by modulating the genetic or metabolic activities of our body. In this study, we performed phytochemical evaluation and antimicrobial assay of ginger root extract which were available in our local farms of Lahore. Ginger possesses a noticeable antimicrobial activity which was confirmed by checking the susceptibility of different strains of bacteria and fungus by measuring the zone of inhibition. In the light of several socioeconomic factors of Pakistan mainly poverty and poor hygienic condition, present study encourages the use of spices as alternative or supplementary medicine to reduce the burden of high cost, side effects and progressively increasing drug resistance of pathogens.
    [Show full text]
  • Dietary Compounds for Targeting Prostate Cancer
    Review Dietary Compounds for Targeting Prostate Cancer Seungjin Noh 1, Eunseok Choi 1, Cho-Hyun Hwang 1, Ji Hoon Jung 2, Sung-Hoon Kim 2 and Bonglee Kim 1,2,* 1 College of Korean Medicine, Kyung Hee University, Seoul 02453, Korea; [email protected] (S.N.); [email protected] (E.C.); [email protected] (C.-H.H.) 2 Department of Pathology, College of Korean Medicine, Graduate School, Kyung Hee University, Seoul 02453, Korea; [email protected] (J.H.J.); [email protected] (S.-H.K.) * Correspondence: [email protected]; Tel.: +82-2-961-9217 Received: 10 August 2019; Accepted: 17 September 2019; Published: 8 October 2019 Abstract: Prostate cancer is the third most common cancer worldwide, and the burden of the disease is increased. Although several chemotherapies have been used, concerns about the side effects have been raised, and development of alternative therapy is inevitable. The purpose of this study is to prove the efficacy of dietary substances as a source of anti-tumor drugs by identifying their carcinostatic activities in specific pathological mechanisms. According to numerous studies, dietary substances were effective through following five mechanisms; apoptosis, anti-angiogenesis, anti- metastasis, microRNA (miRNA) regulation, and anti-multi-drug-resistance (MDR). About seventy dietary substances showed the anti-prostate cancer activities. Most of the substances induced the apoptosis, especially acting on the mechanism of caspase and poly adenosine diphosphate ribose polymerase (PARP) cleavage. These findings support that dietary compounds have potential to be used as anticancer agents as both food supplements and direct clinical drugs.
    [Show full text]
  • The Anti-Leukemic Activity of Natural Compounds
    molecules Review The Anti-Leukemic Activity of Natural Compounds Coralia Cotoraci 1,*,†, Alina Ciceu 2,† , Alciona Sasu 1,†, Eftimie Miutescu 3,† and Anca Hermenean 2,4 1 Department of Hematology, Faculty of Medicine, Vasile Goldis Western University of Arad, Rebreanu 86, 310414 Arad, Romania; [email protected] 2 “Aurel Ardelean” Institute of Life Sciences, Vasile Godis Western University of Arad, Rebreanu 86, 310414 Arad, Romania; [email protected] (A.C.); [email protected] (A.H.) 3 Department of Gastroenterology, Faculty of Medicine, Vasile Goldis Western University of Arad, Rebreanu 86, 310414 Arad, Romania; [email protected] 4 Department of Histology, Faculty of Medicine, Vasile Goldis Western University of Arad, Rebreanu 86, 310414 Arad, Romania * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: The use of biologically active compounds has become a realistic option for the treatment of malignant tumors due to their cost-effectiveness and safety. In this review, we aimed to highlight the main natural biocompounds that target leukemic cells, assessed by in vitro and in vivo experiments or clinical studies, in order to explore their therapeutic potential in the treatment of leukemia: acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphocytic leukemia (ALL), and chronic lymphocytic leukemia (CLL). It provides a basis for researchers and hematologists in improving basic and clinical research on the development of new alternative therapies in the fight against leukemia, a harmful hematological cancer and the leading cause of death among patients. Keywords: antioxidants; flavonoids; anti-leukemic; myeloid leukemia; lymphoblastic leukemia Citation: Cotoraci, C.; Ciceu, A.; Sasu, A.; Miutescu, E.; Hermenean, A.
    [Show full text]
  • Gingerol Aspirinate As a Novel Chemopreventive
    www.nature.com/scientificreports OPEN Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Received: 06 June 2016 Accepted: 02 December 2016 Aspirin for Colon Cancer Published: 09 January 2017 Yingdong Zhu1,*, Fang Wang1,2,*, Yantao Zhao1, Pei Wang1 & Shengmin Sang1 A growing body of research suggests daily low-dose aspirin (ASA) reduces heart diseases and colorectal cancers. However, the major limitation to the use of aspirin is its side effect to cause ulceration and bleeding in the gastrointestinal tract. Preclinical studies have shown that ginger constituents ameliorate ASA-induced gastric ulceration. We here report the design and synthesis of a novel prodrug of aspirin, [6]-gingerol aspirinate (GAS). Our data show that GAS exerts enhanced anti-cancer properties in vitro and superior gastroprotective effects in mice. GAS was also able to survive stomach acid and decomposed in intestinal linings or after absorption to simultaneously release ASA and [6]-gingerol. We further present that GAS inactivates both COX-1 and COX-2 equally. Our results demonstrate the enhanced anticancer properties along with gastroprotective effects of GAS, suggesting that GAS can be a therapeutic equivalent for ASA in inflammatory and proliferative diseases without the deleterious effects on stomach mucosa. Ginger (Zingiber officinale) is widely used as a spice and an ingredient in traditional herbal medicine. The rhizome of ginger has been shown to ameliorate symptoms such as inflammation, rheumatic disorders, gastrointestinal discomforts, and nausea and vomiting associated with pregnancy1. Considerable evidences in preclinical and clinical studies have been reported regarding the gastroprotective effects of ginger root extracts or ginger essential oils2–5.
    [Show full text]